Gelatin Market Overview Analysis By Fortune Business Insights
Market Size & Growth Outlook
According to Fortune Business Insights: The global gelatin market was valued at USD 3.40 billion in 2025 and is projected to grow from USD 3.60 billion in 2026 to USD 6.58 billion by 2034, exhibiting a CAGR of 7.83% during the forecast period. Europe dominated the market with a 41.37% share in 2025, valued at USD 1.40 billion — driven by robust demand across food and beverages, cosmetics, and pharmaceutical applications, particularly in Germany, France, Belgium, and the Netherlands, which collectively host some of the world's largest gelatin manufacturing operations.
Gelatin is a translucent, flavorless protein derived primarily from the collagen found in animal connective tissues — including pig skin, bovine hides, and bones. Its exceptional gelling, stabilizing, thickening, and foaming properties make it indispensable across a wide range of applications spanning confectionery, dairy products, dietary supplements, pharmaceutical capsules, wound dressings, cosmetic formulations, and biomedical research. The market is experiencing robust growth driven by surging demand for functional food and beverages, increasing pharmaceutical applications, and growing preference for clean-label and naturally derived ingredients across multiple industries.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/107012
Market Trends
Rising Demand for Functional Foods and Nutritional Supplements: The defining trend shaping the global gelatin market is the accelerating consumer shift toward functional food and beverages that offer quantifiable health and nutritional benefits beyond basic dietary value. As awareness of food quality and health advantages grows, consumers are increasingly prioritizing ingredient transparency, protein content, and nutritional functionality in their food purchases. Gelatin's natural protein and amino acid content — which supports joint health, skin elasticity, gut health, bone density, and muscle recovery — is positioning it as a valued functional ingredient in dietary supplements, fortified snacks, gummies, and nutraceuticals. Rising demand for dietary supplements to boost immunity, promote skin health, and support active recovery is further sustaining strong sales growth across the food and pharmaceutical application segments. In August 2020, PB Leiner launched Textura Tempo Ready — a clean-label gelatin product without additives and consisting of 100% gelatin — that reduces preparation time by 50% compared to regular leaf form, exemplifying product innovation aligned with clean-label and convenience trends.
Market Drivers
Increasing Application in Healthcare and Pharmaceuticals: The primary growth driver is the expanding use of gelatin across the healthcare and pharmaceutical industries, sustained by the rising global incidence of chronic and lifestyle-related diseases, growing geriatric populations, and escalating healthcare expenditure. Gelatin serves multiple critical pharmaceutical functions — as a primary material for hard and soft capsule shells, as a stabilizer in vaccines (helping ensure safety and efficacy during storage), and as a key component in hemostatic sponges, wound dressings, and blood volume substitutes. The GELFOAM Sterile sponge — a gelatin-based hemostatic medical device for controlling bleeding at wound surfaces — exemplifies the product's critical role in trauma and surgical care. According to the Population Reference Bureau, approximately 1.2 million people are killed in road crashes annually, with as many as 50 million injured — generating significant and sustained demand for gelatin-based hemostatic and orthopedic medical products. In April 2020, ISDIN launched SunISDIN Softgel Capsules in the U.S. — a supplement supporting skin health and oxidative stress prevention — reflecting dermatological companies' growing adoption of gelatin-based delivery formats.
Rising Demand for Clean-Label Products: Growing consumer preference for additive-free, naturally derived, and traceable ingredients is a significant driver for gelatin across food, nutraceutical, cosmetic, and pharmaceutical applications. Manufacturers are responding by developing clean-label gelatin formulations without artificial preservatives or synthetic additives — and by prioritizing transparency in sourcing and processing. In August 2019, ACG Capsules launched a new line of clean-label advanced HPMC capsules for the pharmaceuticals and nutraceuticals industry, reflecting the broader sector commitment to clean and transparent ingredient standards.
Market Restraints
Rising Adoption of Plant-Based Substitutes and Livestock Supply Chain Disruptions: The primary restraint is the growing consumer interest in vegan and plant-based alternatives to animal-derived gelatin — including agar-agar, pectin, carrageenan, and guar gum — driven by rising veganism, religious dietary restrictions, and environmental consciousness. Porcine gelatin is not acceptable among Muslim and Jewish communities due to religious dietary laws, limiting its commercial application in several large markets. Additionally, geopolitical instability has disrupted livestock supply chains. The Russia-Ukraine conflict created economic instability that impacted animal feed supplies, and according to the European Commission, the bovine population decreased by 2% and the pig population by 5% in May/June 2022 compared with the same period in 2021 — directly constraining the supply of animal by-products essential for gelatin production in Europe.
Segmentation Analysis
By Source: Porcine dominates with a projected 52.72% market share in 2026, driven by the cost-effectiveness and high yield of pig-skin-derived gelatin compared to other sources. Porcine gelatin also functions as a stabilizer in vaccines — providing superior storage performance relative to other sources — reinforcing its critical pharmaceutical role. The bovine segment is growing substantially, particularly among athletes and fitness enthusiasts for whom bovine gelatin's amino acid profile supports faster recovery, improved endurance, and performance benefits. Bovine gelatin is also widely adopted in the Middle East and other Muslim-majority markets as a halal-compliant alternative to porcine gelatin. The others segment — encompassing fish, poultry, and other marine sources — is growing steadily, driven by interest in sustainable, allergen-reduced, and non-mammalian gelatin alternatives for premium nutraceutical and cosmetic applications.
By Application: Food and beverages dominates with a projected 60.23% share in 2026, reflecting gelatin's extensive use in confectionery (gummy bears, marshmallows, jelly beans), dairy products (yogurt, cream cheese, ice cream), snacks, desserts, and cooking applications. Its role as a food stabilizer and texture enhancer for products including pasta, jams, and jellies underpins consistent high-volume demand. The healthcare and pharmaceuticals segment is expanding at a considerable CAGR, supported by growing capsule production, vaccine stabilization requirements, wound care applications, and emerging biomedical research in regenerative medicine and drug delivery. The cosmetics segment is growing steadily — gelatin's film-forming and collagen-building properties are valued in face creams, body lotions, shampoos, sunscreens, and hair care products for their skin-smoothening, anti-aging, and hair-strengthening benefits.
Regional Outlook
Europe leads the global market at USD 1.40 billion in 2025 (41.37% share), projected to reach USD 1.50 billion in 2026. The region's dominant position reflects the presence of major gelatin manufacturing facilities, the growing prevalence of bone and joint disorders driving pharmaceutical and nutraceutical gelatin demand, and a strong cosmetics industry — particularly in Germany, where consumer willingness to spend on premium cosmetics and hair care products sustains robust demand. Germany is projected to reach USD 0.51 billion by 2026, while the U.K. is projected at USD 0.11 billion.
Asia Pacific was valued at USD 0.87 billion in 2025 (25.77% share), projected to reach USD 0.93 billion in 2026. The region's growth is driven by rising chronic disease incidence, a rapidly aging population, increasing R&D investment in pharmaceutical manufacturing, and growing cultural demand for gelatin-based food products. Chinese soup dumplings — which rely on gelatin to create their characteristic broth-filled interiors — represent a distinctive and enduring demand driver alongside Western-style confectionery. Japan is projected to reach USD 0.31 billion by 2026, while India is projected at USD 0.13 billion and China at USD 0.11 billion.
North America contributed 15.50% to the global market in 2025 (USD 0.53 billion), projected to reach USD 0.56 billion in 2026. The market is primarily driven by the food and beverage industry, where shifting consumer preferences toward health-oriented products, clean-label ingredients, and functional nutritional formats — including high-protein snacks and supplement gummies — are sustaining demand. The U.S. market is projected to reach USD 602.32 million by 2032, driven by demand from bakeries, beverage manufacturers, and dietary supplement companies.
Latin America accounted for USD 0.35 billion in 2025 (10.41% share), projected to grow to USD 0.37 billion in 2026, driven by rising urbanization, expanding packaged food consumption, and growing demand for convenience food products incorporating gelatin.
Middle East & Africa reached USD 0.24 billion in 2025 (6.96% share), projected to reach USD 0.25 billion in 2026. The region's booming halal sector is a key growth driver — fueling demand for bovine and fish-source gelatin across nutraceuticals, pharmaceuticals, and functional food products. Manufacturers are expanding production facilities and halal certification programs to capture this demand.
Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/107012
Competitive Landscape
The global gelatin market exhibits a moderately consolidated structure, with leading players including Gelita AG (Germany), Darling Ingredients Inc. (U.S.), Nitta Gelatin Inc. (Japan), Tessenderlo Group (Belgium), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.a. (Italy), Juncà Gelatines SL (Spain), Italgel S.r.l. (Italy), Sterling Biotech Ltd. (India), and Gelnex (Brazil). Gelita AG and Darling Ingredients hold particularly strong market positions through their broad product portfolios, global manufacturing networks, and continuous investment in new product development and strategic acquisitions.
Key recent developments include Darling Ingredients' December 2023 patent for its specialized StabiCaps gelatin formulation improving soft gel capsule stability; GELITA's May 2023 launch of fast-setting gelatin for fortified gummy production; Darling Ingredients/Rousselot Health's January 2022 partnership with Terasaki Institute for Biomedical Innovation for gelatin-based regenerative medicine therapies; Rousselot's October 2021 launch of QualiPure for biomedical applications including wound healing, drug delivery, and vaccines; Nitta Gelatin India's January 2021 launch of premium international-standard gelatin for the HoReCa desserts and confectionery market; and Gelita AG's March 2020 acquisition of a 65% stake in Turkish manufacturer SelJel to expand its halal bovine gelatin production capacity.
What Everyone Should Know About Japan’s Market - Gelatin Market Insights